Bellevue Group AG logo

Bellevue Group AG (BBNz)

Market Closed
CBOE CBOE
- Market Cap
10.32 P/E Ratio
4.6% Div Yield
- Volume
0.97 Eps
Want to track BBNz and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

BBNz pays dividends to its shareholders, with the most recent payment made on Apr 02, 2026.
The stock of the company had never split.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on XDUS (EUR).

Bellevue Group AG (BBNz) FAQ

On which exchange is it traded?

Bellevue Group AG is listed on CBOE.

What is its stock symbol?

The ticker symbol is BBNz.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 4.6%.

What is its market cap?

As of today, no market cap data is available.

Has Bellevue Group AG ever had a stock split?

No, there has never been a stock split.

Bellevue Group AG Profile

Capital Markets Industry
Financials Sector
Mr. Gebhard Giselbrecht CEO
CBOE Exchange
- ISIN
Switzerland Country
94 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Bellevue Group AG is a premier asset management firm based in Küsnacht, Switzerland, established in 1993. The company has carved a niche for itself by providing exceptional asset management services across Switzerland, the United Kingdom, and Germany. Bellevue Group AG specializes in catering to the investment needs of institutional, intermediary, and private clients, offering a wide array of investment products and solutions tailored to meet diverse financial goals and market opportunities.

Products and Services

The Bellevue Group AG offers a comprehensive range of investment products and services designed to suit various investor needs, including:

  • Healthcare Investment Products: These products encompass investments in biotech, MedTech, thematic, and global and regional healthcare sectors. Bellevue Group AG leverages its expertise to provide clients with exposure to the healthcare industry’s high growth potential, focusing on innovation and advancements in medical technology and biological sciences.
  • Small and Mid-Sized Entrepreneur Investment Products: This category features investment opportunities in listed small and mid caps, as well as private equity strategies. These products are tailored for investors looking to capitalize on the agility and innovation of small and mid-sized enterprises (SMEs), which often present unique growth opportunities.
  • Yield Investment Products: Bellevue Group AG’s yield-oriented products include multi asset, bonds, and alternative investment options. These products are designed for investors seeking regular income streams, diversification, and potential risk mitigation, through a mix of fixed income, equities, and alternative assets.

In addition to these primary investment avenues, the Bellevue Group AG also manages and offers various investment funds, further diversifying its product portfolio to meet the eclectic needs of its clients. Moreover, the company prides itself on delivering bespoke investment solutions, ensuring that the financial objectives of institutional, intermediary, and private clients are met with precision and care.

Contact Information

Address: Seestrasse 16
Phone: 41 44 267 67 00